Nicotine: Does it have a role in the treatment of skin disease?

Postgraduate Medical Journal

Volumn 85, Issue 1002, 2009, Pages 196-201

  Ingram, J R ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; STEROID; TUMOR NECROSIS FACTOR ALPHA;

APHTHOUS ULCER; BEHCET DISEASE; CANCER RISK; CIGARETTE SMOKING; CLINICAL TRIAL; DIZZINESS; DRUG ABSORPTION; DRUG EFFECT; DRUG MEGADOSE; DRUG TOLERANCE; HEADACHE; HUMAN; LOW DRUG DOSE; MELANOMA; NAUSEA; NONHUMAN; PEMPHIGUS; PROTEIN FUNCTION; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; PYODERMA GANGRENOSUM; REVIEW; RISK REDUCTION; SIDE EFFECT; SKIN DISEASE; SKIN INFLAMMATION; SMOKING CESSATION; SMOKING HABIT; SWEATING; TOBACCO DEPENDENCE; TREMOR; VOMITING; WELLS SYNDROME;

DERMATOLOGIC AGENTS; HUMANS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SKIN; SKIN DISEASES; SMOKING;

EID: 65749109496     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2008.073577     Document Type: Review

References (100)

1. MacKenzie C. Sublime tobacco. 1st edn. London: Chatto and Windus, 1957.
2. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. BMJ 1954;1:1451-1455
3. Freiman A, Bird G, Metelitsa AI, et al. Cutaneous effects of smoking. J Cutan Med Surg 2004;8:415-423
4. Eriksson MO, Hagforsen E, Lundin IP, et al. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 1998;138:390-398
5. Mills CM, Srivastava ED, Harvey IM, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992;127:18-21.
6. Fortes C, Mastroeni S, Leffondre K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005;141:1580-1584
7. Konig A, Lehmann C, Rompel R, et al. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 1999;198:261-264
8. Kostenbader KH, Kim DJ, Peerzada, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004;50:849-857
9. Zheng TZ, Boyle P, Hu HF, et al. Tobacco smoking, alcohol consumption, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1990;1:173-179
10. Chang DW, Reece GP, Wang B, et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg 2000;105:2374-2380
11. Mosley JG, Gibbs AC. Premature grey hair and hair loss among smokers: a new opportunity for health education? BMJ 1996;313:1616.
12. Grodstein F, Speizer FE, Hunter DJ. A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study. J Natl Cancer Inst 1995;87:1061-1066
13. Odenbro A, Bellocco R, Boffetta P, et al. Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden. Br J Cancer 2005;92:1326-1328
14. Mills CM, Peters TJ, Finlay AY. Does smoking influence acne? Clin Exp Dermatol 1993;18:100-101
15. Klaz I, Kochba I, Shohat T, et al. Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol 2006;126:1749-1752
16. Schafer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001;145:100-104
17. De Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol 2001;19:231-238
18. van Dam RM, Huang Z, Rimm EB. Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 1999;150:459-468 (Pubitemid 29407229)
19. Corona R, Dogliotti E, D'Errico M, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001;137:1162-1168
20. Mills CM, Srivastava ED, Harvey IM, et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994;33:33-34
21. Osterlind A, Tucker MA, Stone BJ, et al. The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer 1988;42:825-828
22. Valikhani M, Kavusi S, Chams-Davatchi M, et al. Pemphigus and associated environmental factors: a case-control study. Clin Exp Dermatol 2007;32:256-260
23. Brenner S, Tur E, Shapiro J, et al. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001;40:562-569
24. Sullivan TP, Elgart GW, Kirsner RS. Pemphigus and smoking. Int J Dermatol 2002;41:528-530
25. Soy M, Erken E, Konca K, et al. Smoking and Behcet's disease. Clin Rheumatol 2000;19:508-509
26. Marakoglu K, Sezer RE, Toker HC, et al. The recurrent aphthous stomatitis frequency in the smoking cessation people. Clin Oral Investig 2007;11:149-153
27. Chattopadhyay A, Chatterjee S. Risk indicators for recurrent aphthous ulcers among adults in the US. Community Dent Oral Epidemiol 2007;35:152-159
28. Salonen L, Axell T, Hellden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med 1990;19:170-176 (Pubitemid 20228778)
29. Grady D, Ernster VL, Stillman L, et al. Smokeless tobacco use prevents aphthous stomatitis. Oral Med Oral Pathol 1992;74:463-465
30. Axell T, Liedholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scand 1990;48:119-123 (Pubitemid 20218780)
31. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 2002;94:1712-1718
32. Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999;10:21-25
33. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-1854.
34. Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine-a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2005;2:536-544 (Pubitemid 43135272)
35. Patel GK, Rhodes J, Evans BK, et al. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatol Treat 2004;15:122-125
36. Green JT, Rhodes J, Thomas GAO, et al. Nicotine carbomer enemas: pharmacokinetics of a revised formulation. Ital J Gastroenterol Hepatol 1998;30:260-265
37. Green JT, Evans BK, Rhodes J, et al. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br J Clin Pharmacol 1999;48:485-493
38. Benowitz NL. Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-1330
39. Benowitz NL, Jacob P III. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504. (Pubitemid 14133490)
40. Benowitz NL, Jacob P III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-493 (Pubitemid 24370355)
41. Balfour DJ. The effects of nicotine on brain neurotransmitter systems. Pharmacol Ther 1982;16:269-282 (Pubitemid 12017542)
42. Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577
43. Ingram JR, Rhodes J, Evans BK, et al. Preliminary observations of oral nicotine therapy for inflammatory bowel disease: an open-label phase I-II study of tolerance. Inflamm Bowel Dis 2005;11:1092-1096
44. Collins A, Marks M. Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev Res 1996;38:231-242
45. Jarvik ME, Madsen DC, Olmstead RE, et al. Nicotine blood levels and subjective craving for cigarettes. Pharmacol Biochem Behav 2000;66:553-558
46. Henningfield JE, Goldberg SR. Nicotine as a re-inforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 1983;18:989-992 (Pubitemid 14209524)
47. Henningfield JE, Miyasato K, Jasinski DR. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 1985;234:1-12. (Pubitemid 15034883)
48. Russell MAH. Nicotine intake by smokers: are rates of absorption or steady-state levels important? In: Rand MJ, Thurau K, eds. The pharmacology of nicotine (ICSU Symposium Series: Volume 9). 1st edn. Oxford: IRL Press, 1988:375-402.
49. Thomas GAO, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995b;332:988-992
50. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996;36:597-613. (Pubitemid 26168710)
51. Pich E, Paglusi S, Tessari M, et al. Common neural substrates for the addictive properties of nicotine and cocaine. Science 1997;265:83-86
52. Walters CL, Brown S, Changeux JP, et al. The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 2006;184:339-344
53. Zhou H, Calaf GM, Hei TK. Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone. Int J Cancer 2003;106:821-826 (Pubitemid 37071659)
54. Hoffmann D, Djordjevic MV. Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res 1997;11:322-329
55. Heusch WL, Maneckjee R. Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis 1998;19:551-556 (Pubitemid 28376796)
56. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-839
57. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-1798
58. Meine TJ, Patel MR, Washam JB, et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005;95:976-978
59. McGrath J, McDonald JW, Macdonald JK. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004;(4):CD004722.
60. Kanekura T, Kanzaki T. Successful treatment of pyoderma gangrenosum with nicotine chewing gum. J Dermatol 1995;22:704-705
61. Wolf R. Nicotine for pyoderma gangrenosum. Arch Dermatol 1998;134:1701-1702 (Pubitemid 28432318)
62. Bittoun R. Recurrent aphthous ulcers and nicotine. Med J Aust 1991;154:471-472
63. Scheid P, Bohadana A, Martinet Y. Nicotine patches for aphthous ulcers due to Behcet's syndrome. N Engl J Med 2000;343:1816-1817.
64. Kaklamani VG, Markomichelakis N, Kaklamanis PG. Could nicotine be beneficial for Behcet's disease? Clin Rheumatol 2002;21:341-342
65. Kuwahara RT, Skinner RB, Rosenberg EW. Nicotine gum for oral lichen planus. J Dermatol 2000;27:755. (Pubitemid 32014636)
66. Kanekura T, Usuki K, Kanzaki T. Skin disorders with prominent eosinophilic infiltration treated successfully with nicotine. Report of two cases. Dermatology 2004;208:153-157
67. Kanekura T, Mera Y, Mera K, et al. Efficacy of transdermal nicotine patches for eosinophilic pustular folliculitis. Br J Dermatol 2005;152:1074-1075
68. Kawabata H, Kanekura T, Gushi A, et al. Successful treatment of digital ulceration in Buerger's disease with nicotine chewing gum. Br J Dermatol 1999;140:187-188
69. Scott DA, Martin M. Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases. World J Gastroenterol 2006;12:7451-7459 (Pubitemid 46017741)
70. Changeux JP, Edelstein SJ. Allosteric receptors after 30 years. Neuron 1998;21:959-980 (Pubitemid 29018068)
71. Karlin A, Akabas M. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 1995;15:1231-1244 (Pubitemid 26005363)
72. Lindstrom J. Purification and cloning of nicotinic acetylcholine receptors. In: Arneric SP, Brioni JD, eds. Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. Hoboken, NJ: Wiley Liss, 1998:3-23.
73. Chen D, Patrick JW. The a-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the a7 subunit. J Biol Chem 1997;272:24024-24029 (Pubitemid 27410987)
74. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462
75. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388
76. Shytle RD, Mori T, Townsend K, et al. Cholinergic modulation of microglial activation by a7 nicotinic receptors. J Neurochem 2004;89:337-343
77. A l'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
78. Pavlov VA, Wang H, Czura CJ, et al. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003;9:125-134
79. Mills CM, Hill SA, Marks R. Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol 1997;133:823-825 (Pubitemid 27337540)
80. Kalayciyan A, Orawa H, Fimmel S, et al. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behçet's disease. J Invest Dermatol 2007;127:81-89
81. Lang PM, Burgstahler R, Sippel W, et al. Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J Neurophysiol 2003;90:3295-3303
82. Kurzen H, Wessler I, Kirkpatrick CJ, et al. The non-neuronal cholinergic system of human skin. Horm Metab Res 2007;39:125-135
83. Grando SA, Horton RM, Pereira EF, et al. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995;105:774-781
84. Misery L. Nicotine effects on skin: are they positive or negative? Exp Dermatol 2004;13:665-670
85. Grando SA, Kist DA, Qi M, et al. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 1993;101:32-36
86. Grando SA, Horton RM, Mauro TM, et al. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996;107:412-418
87. Arredondo J, Nguyen VT, Chernyavsky AI, et al. Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. J Cell Biol 2002;159:325-336
88. Zia S, Ndoye A, Lee TX, et al. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 2000;293:973-981
89. Chernyavsky AI, Arredondo J, Vetter DE, et al. Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization. Exp Cell Res 2007;313:3542-3555
90. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 2000;157:1377-1391
91. Hagforsen E, Edvinsson M, Nordlind K, et al. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 2002;146:383-391
92. Hana A, Booken D, Henrich C, et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 2007;80:2214-2220
93. Arredondo J, Chernyavsky AI, Jolkovsky DL, et al. Receptor-mediated tobacco toxicity: acceleration of sequential expression of alpha5 and alpha7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke. FASEB J 2008;22:1356-1368
94. West R, McNeill A, Raw M. Smoking cessation guidelines for the health professionals: an update. Thorax 2000;55:987-999
95. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther 2005;21:921-931 (Pubitemid 40529727)
96. Ingram JR, Thomas GA, Rhodes J, et al. A randomized trial of nicotine enemas for active ulcerative colitis. Clin Gastroenterol Hepatol 2005;3:1107-1114
97. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
98. Edwards R. The problem of tobacco smoking. BMJ 2004;328:217-219
99. Forgacs PB, Bodis-Wollner I. Nicotinic receptors and cognition in Parkinson's disease: the importance of neuronal synchrony. J Neural Transm 2004;111:1317-1331 (Pubitemid 39468393)
100. Oddo S, LaFerla FM. The role of nicotinic acetylcholine receptors in Alzheimer's disease. J Physiol Paris 2006;99:172-179